Nektar Therapeutics | NKTR - Operating Expenses


Nektar Therapeutics reported $85.09M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Agios Pharmaceuticals USD 141.54M 11.8M Dec/2025
ALKERMES USD 326.44M 1.41B Dec/2025
Alterity Therapeutics Limited AUD 7.78M 3M Jun/2023
Amgen USD 5.9B 773M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
BioCryst Pharmaceuticals USD -387.89M 33.7M Sep/2025
Biogen USD 1.88B 81.4M Sep/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
Cara Therapeutics USD 4.96M 2.38M Mar/2025
Cipla INR 60.98B 1.06B Dec/2025
Dr.Reddys Laboratories INR 73.6B 1.79B Dec/2025
Eisai JPY 199.9B 16.22B Dec/2025
Eli Lilly USD 10.31B 1.09B Dec/2025
Esperion Therapeutics USD 67.66M 3.6M Sep/2024
Exelixis USD 362.75M 21.35M Dec/2025
Gilead Sciences USD 4.96B 707M Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
Grifols EUR 1.77B 22.04M Sep/2025
Halozyme Therapeutics USD 211.07M 74.73M Dec/2025
Incyte USD 1.12B 3.53B Dec/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
Ironwood Pharmaceuticals USD 57.33M 8.63M Dec/2024
Karyopharm Therapeutics USD 61.82M 3.24M Dec/2024
MacroGenics USD 67M 8M Sep/2025
Merck USD 10.16B 558M Dec/2025
Nektar Therapeutics USD 85.09M 109.3M Sep/2025
Neurocrine Biosciences USD 577.6M 22M Dec/2025
Novartis USD 9.86B 115M Sep/2025
Pfizer USD 12.91B 79.89B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sarepta Therapeutics USD 853.02M 390.78M Dec/2025
Takeda JPY 1.02T 400.98B Dec/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025
Xencor USD 81.86M 13.35M Dec/2025